AbsciABSI
Fair Value
US$10
Share price18 Dec
US$8.0719.3% undervalued intrinsic discount
1Y179.24%
7D-2.71%
AI-Driven Antibody Platform Will Unlock Major Aesthetic And Women’s Health Markets
AN
Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls
Published
18 Dec 25
Views
70
Not Invested